Evidence map›Paper›PMID 16914744›Full record

ArticleMolecular and cellular biology2006

Cytohesin binder and regulator (cybr) is not essential for T- and dendritic-cell activation and differentiation.

Wendy T Watford, Denise Li, Davide Agnello, Lydia Durant, Kunihiro Yamaoka, Zheng Ju Yao, Hyun-Jong Ahn, Tammy P Cheng, Sigrun R Hofmann, Tiziana Cogliati and 6 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Elucidating the Role of Pelargonidin-3-O-Glucoside onJournal of pharmacy & bioallied sciences · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Wendy T WatfordLCBS-MIIB-NIAMS-NIH, Bldg. 10, Room 9N256, MSC-1820, 10 Center Dr., Bethesda, MD 20892-1820, USA. watfordw@mail.nih.gov
Denise Li
Davide Agnello
Lydia Durant
Kunihiro Yamaoka
Zheng Ju Yao
Hyun-Jong Ahn
Tammy P Cheng
Sigrun R Hofmann
Tiziana Cogliati
Amy Chen
Bruce D Hissong
Matthew R Husa
Pamela Schwartzberg
John J O'Shea
Massimo Gadina
Institut thématique Immunologie, inflammation, infectiologie et microbiologie · FRNational Institutes of Health · USCancer Genetics (United States) · USNational Human Genome Research Institute · US

Funding

Genetic and Biochemical Approaches to Tyrosine Kinase FunctionZIAHG000123 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SCHWARTZBERG, PAMELA · 2009 to 2018
$20.8M
Targeting Janus kinases in the treatment of autoimmune diseaseZIAAR041106 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI O'SHEA, JOHN · 2009 to 2024
$4.8M
Genetic/Biochemical Approaches-Tyrosine Kinase FunctionZ01HG000123 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SCHWARTZBERG, PAMELA · 1998 to 2008
$4.7M
Targeting Jak3 in the treatment of autoimmune diseaseZ01AR041106 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI O'SHEA, JOHN J. · 1995 to 2008
$2.7M
Intramural NIH HHS
6 · The paper itself

Abstract

Cybr (also known as Cytip, CASP, and PSCDBP) is an interleukin-12-induced gene expressed exclusively in hematopoietic cells and tissues that associates with Arf guanine nucleotide exchange factors known as cytohesins. Cybr levels are dynamically regulated during T-cell development in the thymus and upon activation of peripheral T cells. In addition, Cybr is induced in activated dendritic cells and has been reported to regulate dendritic cell (DC)-T-cell adhesion. Here we report the generation and characterization of Cybr-deficient mice. Despite the selective expression in hematopoietic cells, there was no intrinsic defect in T- or B-cell development or function in Cybr-deficient mice. The adoptive transfer of Cybr-deficient DCs showed that they migrated efficiently and stimulated proliferation and cytokine production by T cells in vivo. However, competitive stem cell repopulation experiments showed a defect in the abilities of Cybr-deficient T cells to develop in the presence of wild-type precursors. These data suggest that Cybr is not absolutely required for hematopoietic cell development or function, but stem cells lacking Cybr are at a developmental disadvantage compared to wild-type cells. Collectively, these data demonstrate that despite its selective expression in hematopoietic cells, the role of Cybr is limited or largely redundant. Previous in vitro studies using overexpression or short interfering RNA inhibition of the levels of Cybr protein appear to have overestimated its immunological role.

Indexed as

Cell DifferentiationAnimalsCarrier ProteinsCross-PrimingCytokinesDendritic CellsExonsGene Expression RegulationGene TargetingHumansImmunity, InnateLipopolysaccharidesLymphocyte SubsetsMembrane ProteinsMiceMice, KnockoutCarrier ProteinsCybr protein, mouseCytokinesLipopolysaccharidesMembrane ProteinsRNA, Messenger

Identifiers

PMID16914744
PMCPMC1592848
OpenAlexW2046200333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.